Cargando…
BSCI-27. MELATONIN REDUCES MALIGNANCY OF BREAST CANCER BRAIN METASTATIC CELLS
Around fifteen to thirty percent of stage IV breast cancer metastasizes to the brain, severely decreasing the quality of life of these patients by causing neurological decline and eventually death. In metastatic cancers there is a small subset of cells in the primary tumor bulk called Metastatic Tum...
Autores principales: | Gil, Beatriz Fernandez, Rodriguez, Katherine, Schiapparelli, Paula, Ramos, Carla Vazquez, Escames, Germaine, Quinones-Hinojosa, Alfredo, Sarabia-Estrada, Rachel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213190/ http://dx.doi.org/10.1093/noajnl/vdz014.023 |
Ejemplares similares
-
DDRE-33. MELATONIN AS A MASTER METABOLIC SWITCH FOR GLIOBLASTOMA
por: Fernandez-Gil, Beatriz Irene, et al.
Publicado: (2021) -
Melatonin Treatment Triggers Metabolic and Intracellular pH Imbalance in Glioblastoma
por: Fernandez-Gil, Beatriz I., et al.
Publicado: (2022) -
BSCI-16. HEMODYNAMIC SHEAR STRESS SELECTS A SUBPOPULATION OF LUNG ADENOCARCINOMA CELLS WITH HIGHER METASTATIC CAPACITY
por: Alvarado-Estrada, Keila N, et al.
Publicado: (2019) -
Circulatory shear stress induces molecular changes and side population enrichment in primary tumor-derived lung cancer cells with higher metastatic potential
por: Alvarado-Estrada, Keila, et al.
Publicado: (2021) -
BSCI
por: Shannon Michael J
Publicado: (2004)